Connect with Us
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.
Helen Kane is a pharmacist by background and had a successful 25 year career in Medical Affairs working at Novartis, Roche and Celgene. In 2010 Helen was a founding member of the first professional association for MSLs within the UK and Ireland, the MSLA. She was proud to serve as Chair between 2012-15 and it was during this time that she became recognised as a passionate advocate for the MSL. In 2016 Helen left corporate life and became a consultant with a core focus on supporting organisations to deliver and drive MSL excellence. As the demand for her consultancy services grew, Helen launched One MSL as a specialist medical affairs training consultancy with a mission to maximise the impact of the MSL and wider medical function in an evolving industry.
Helen is often heard to say that is indeed a beautiful thing which a passion and a career come together. She engages widely within pharma through webinars, podcasts, surveys and social media. Helen is proud to be involved with MAPs and is truly honoured to be the MAPs Co-Chapter lead for the UK and Ireland.
Dr. João Dias is an honors graduate of the University of Helsinki. He received his Licentiate/MSc in biochemistry from the Universities of Porto, Portugal and Wageningen, the Netherlands; and his PhD studies in Immuno-Oncology and Gene Therapy at Helsinki University Central Hospital and Helsinki University, faculty of Medicine.
He is currently responsible for international medical affairs and clinical development for the medical devices and diagnostics portfolio at Haemonetics which includes Hemostasis Management, Cell Salvage and Transfusion Management products. Prior to this role, João had a variety of roles of increasing responsibility in the areas of both market access and medical marketing.
He has authored several peer-reviewed publications and white papers in the fields of Hemostasis, Patient Blood Management, Immuno-Oncology, Gene Therapy, Hematology, and Molecular Biology.
Prior to his tenure at Haemonetics, João worked as a scientist in the development of new products in Cancer Gene Therapy and served as a Life Sciences Consultant working together with multiple global life-science companies.”
Dr Ashton Harper studied medicine at University College London graduating with both an MBBS and a B.Sc. in physiology and pharmacology. He worked as a doctor in the NHS and trained as a gastrointestinal surgeon achieving membership of the Royal College of Surgeons. During training he was awarded a post-graduate travelling fellowship to visit the Cleveland Clinic in the USA to observe world leading doctors manage inflammatory bowel disease. In 2015 he joined Protexin, a UK based biotechnology company developing microbiome focused products. Ashton was the Medical Director for the company following its acquisition by ADM in 2018. He joined Roche Diagnostics in August 2020 as Head of Medical Affairs for the UK & Ireland where he leads a team responsible for clinical research across oncology, cardiology, neurology, infectious diseases, critical care and women’s health. During his career in industry he has designed and initiated numerous novel interventional clinical trials in a range of therapeutic areas and has lectured frequently on an international stage. He has published in the fields of surgery, gastroenterology, neurology, infectious diseases and microbiology, and has presented his work at multiple national and international medical congresses.
Dr. Younes joined CSL Behring in April 2022 as Head of Medical Affairs Middle East & Africa with 15 years of experience in the pharmaceutical industry in Europe and Middle East.
Prior to joining CSL Behring, he held the position of GCC Cluster Medical Lead for Kyowa Kirin Pharma where he successfully established the medical organization and strategy for the region.
Previously, Dr. Younes held various positions within Novartis, Roche Pharma and Gilead Sciences in France and then in Middle East where he was providing medical support, developing Phase 3/4 clinical trials and initiating national awareness and educational programs. A native of Tunisia, Dr. Younes received his medical degree from the University of Tunis, Tunisia. He went on to receive his Oncology Specialized Certification from The University of Paris VI France. A long with the industry journey, Dr Younes completed medical specialized courses from the university of Paris V (Geriatrics & HIV management) and from Harvard Medical School (Immunology & Genetics).
William is a Director, Quality and Risk Management, Global Medical and Safety Governance, supporting the Africa and Developing Countries of Asia at GlaxoSmithKline. In his role, William he is responsible for providing technical support to Country Medical Teams across 53 distinct countries medical affairs, governance, pharmacovigilance, medical information and human subject research, aiming to strengthen and drive simplification in the operating model. At a Global level, he links the local units with the global teams driving organizational alignment and feeding into the development of global medical governance strategies.
He began his career with GSK in 2011 as a Medical Advisor supporting 13 East African countries and worked across a wide range of medical affairs therapeutic areas including anti-infectives, respiratory, allergy, dermatology, cardiovascular, gastroenterology, oncology, neurosciences and vaccines. He also worked as a nominated safety contact, providing pharmacovigilance oversight to the Eastern African countries. In 2014 he became the Country Medical Director, a position he held for two years.
William is a 2017 Oxford University-African Leadership Institute, Archbishop Desmond Tutu Fellow. He holds a First Class Master’s Degree in Pharmaceutical Medicine from Ireland and is a Bachelor of Medicine and Surgery graduate from the University of Nairobi. He is a Top 40 Under 40 Awardee Kenya – 2015. He has co-authored articles on antibiotic resistance, burden of rotavirus gastroenteritis, influenza shedding and use of webinars for medical education. He was involved in the introduction and of pneumonia and rotavirus vaccines across several East Africa countries while overseeing the development of the new Malaria vaccine. He has been involved in launches of many other products across therapeutic categories within the region.
Prior to joining GSK, William worked for the US CDC as a Researcher and at the Gertrude’s Children’s Hospital as a Doctor. He served patients in Kenya’s largest slum as a Doctor and Board of Trustees member for the University of North Carolina’s Carolina for Kibera program.
602 Park Point Drive, Suite 225, Golden, CO 80401 – +1 303.495.2073
© 2024 Medical Affairs Professional Society (MAPS). All Rights Reserved Worldwide.